HEADER IMMUNE SYSTEM 22-FEB-10 2X70 TITLE CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A PHOTOCLEAVABLE TITLE 2 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: RESIDUES 25-299; COMPND 5 SYNONYM: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B, E; COMPND 10 FRAGMENT: RESIDUES 21-119; COMPND 11 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: HLA-A2.1-RESTRICTED INFLUENZA A MATRIX EPITOPE; COMPND 15 CHAIN: C, F; COMPND 16 FRAGMENT: FRAGMENT RESIDUES 58-66; COMPND 17 ENGINEERED: YES; COMPND 18 OTHER_DETAILS: MODIFIED AT P5 (RESIDUE62) AND P8 (RESIDUE 65).(2- COMPND 19 NITRO)PHENYL-PROPIONIC ACID AT P5 AND 3-AMINO-3-(2-NITRO)PHENYL- COMPND 20 PROPIONIC ACID AT P8 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: XL1 BLUE; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 20 ORGANISM_TAXID: 11320 KEYWDS IMMUNE SYSTEM, AMYLOID, IMMUNOGLOBULIN DOMAIN, IMMUNE RESPONSE, HOST- KEYWDS 2 VIRUS INTERACTION EXPDTA X-RAY DIFFRACTION AUTHOR P.H.N.CELIE,M.TOEBES,B.RODENKO,H.OVAA,A.PERRAKIS,T.N.M.SCHUMACHER REVDAT 7 20-DEC-23 2X70 1 REMARK REVDAT 6 15-NOV-23 2X70 1 REMARK LINK ATOM REVDAT 5 24-APR-19 2X70 1 SEQRES REVDAT 4 06-MAR-19 2X70 1 REMARK LINK REVDAT 3 30-JAN-19 2X70 1 REMARK REVDAT 2 09-MAR-11 2X70 1 REMARK REVDAT 1 08-DEC-10 2X70 0 JRNL AUTH P.H.N.CELIE,M.TOEBES,B.RODENKO,H.OVAA,A.PERRAKIS, JRNL AUTH 2 T.N.M.SCHUMACHER JRNL TITL UV-INDUCED LIGAND EXCHANGE IN MHC CLASS I PROTEIN CRYSTALS. JRNL REF J.AM.CHEM.SOC. V. 131 12298 2009 JRNL REFN ISSN 0002-7863 JRNL PMID 19655750 JRNL DOI 10.1021/JA9037559 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.93 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.380 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 3 NUMBER OF REFLECTIONS : 52222 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.159 REMARK 3 FREE R VALUE : 0.225 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 2753 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.9257 - 5.3945 0.98 2449 136 0.1588 0.2120 REMARK 3 2 5.3945 - 4.2959 0.98 2445 114 0.1074 0.1532 REMARK 3 3 4.2959 - 3.7570 0.98 2428 150 0.1104 0.1737 REMARK 3 4 3.7570 - 3.4154 0.98 2424 138 0.1304 0.2062 REMARK 3 5 3.4154 - 3.1716 0.98 2468 120 0.1460 0.2359 REMARK 3 6 3.1716 - 2.9853 0.98 2448 159 0.1580 0.2369 REMARK 3 7 2.9853 - 2.8362 0.98 2471 130 0.1725 0.2394 REMARK 3 8 2.8362 - 2.7131 0.98 2487 123 0.1806 0.2825 REMARK 3 9 2.7131 - 2.6089 0.98 2502 131 0.1829 0.2434 REMARK 3 10 2.6089 - 2.5190 0.98 2488 146 0.1847 0.2805 REMARK 3 11 2.5190 - 2.4404 0.98 2479 118 0.1868 0.2620 REMARK 3 12 2.4404 - 2.3707 0.98 2516 130 0.1930 0.2832 REMARK 3 13 2.3707 - 2.3084 0.98 2484 133 0.1917 0.2274 REMARK 3 14 2.3084 - 2.2522 0.98 2506 132 0.1914 0.2602 REMARK 3 15 2.2522 - 2.2010 0.98 2503 114 0.2010 0.2445 REMARK 3 16 2.2010 - 2.1543 0.98 2467 137 0.1979 0.2413 REMARK 3 17 2.1543 - 2.1112 0.98 2508 154 0.2020 0.2892 REMARK 3 18 2.1112 - 2.0714 0.98 2471 133 0.2022 0.2454 REMARK 3 19 2.0714 - 2.0345 0.98 2533 124 0.2140 0.2415 REMARK 3 20 2.0345 - 2.0000 0.98 2483 140 0.2171 0.2676 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 48.02 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.290 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 25.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.28840 REMARK 3 B22 (A**2) : 2.75410 REMARK 3 B33 (A**2) : -2.13960 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.63020 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: 0.0430 REMARK 3 OPERATOR: -H,-K,L REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.004 6770 REMARK 3 ANGLE : 1.245 9186 REMARK 3 CHIRALITY : 0.145 924 REMARK 3 PLANARITY : 0.003 1191 REMARK 3 DIHEDRAL : 17.781 2485 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 1:180) REMARK 3 ORIGIN FOR THE GROUP (A): 27.0026 -3.5404 -3.3134 REMARK 3 T TENSOR REMARK 3 T11: 0.0861 T22: 0.0387 REMARK 3 T33: 0.1201 T12: -0.0013 REMARK 3 T13: -0.0072 T23: -0.0212 REMARK 3 L TENSOR REMARK 3 L11: 1.1326 L22: 1.1220 REMARK 3 L33: 2.2773 L12: 0.5334 REMARK 3 L13: -0.0190 L23: -0.5163 REMARK 3 S TENSOR REMARK 3 S11: -0.0203 S12: 0.0677 S13: -0.1216 REMARK 3 S21: 0.0521 S22: 0.0376 S23: -0.3075 REMARK 3 S31: -0.1048 S32: 0.0281 S33: -0.0196 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN A AND RESID 181:275) REMARK 3 ORIGIN FOR THE GROUP (A): -4.1001 -7.6257 -19.8064 REMARK 3 T TENSOR REMARK 3 T11: 0.2026 T22: 0.1995 REMARK 3 T33: 0.1792 T12: -0.0136 REMARK 3 T13: -0.0633 T23: -0.0100 REMARK 3 L TENSOR REMARK 3 L11: 0.8669 L22: 0.5429 REMARK 3 L33: 1.0419 L12: -0.0198 REMARK 3 L13: 0.4194 L23: 0.1279 REMARK 3 S TENSOR REMARK 3 S11: 0.1882 S12: -0.0734 S13: -0.0804 REMARK 3 S21: -0.1066 S22: -0.0873 S23: 0.2420 REMARK 3 S31: 0.2140 S32: -0.2808 S33: -0.0674 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): 6.2716 10.5079 -12.5974 REMARK 3 T TENSOR REMARK 3 T11: 0.2108 T22: 0.1613 REMARK 3 T33: 0.1565 T12: 0.0177 REMARK 3 T13: 0.0570 T23: 0.0219 REMARK 3 L TENSOR REMARK 3 L11: 0.7456 L22: 0.3384 REMARK 3 L33: 1.3712 L12: 0.0471 REMARK 3 L13: -0.0452 L23: -0.3450 REMARK 3 S TENSOR REMARK 3 S11: 0.1065 S12: 0.0574 S13: 0.1256 REMARK 3 S21: -0.0226 S22: 0.0216 S23: 0.0501 REMARK 3 S31: -0.2816 S32: -0.1761 S33: -0.1274 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: (CHAIN D AND RESID 0:179) REMARK 3 ORIGIN FOR THE GROUP (A): 57.6382 3.7595 21.2618 REMARK 3 T TENSOR REMARK 3 T11: 0.1184 T22: 0.1184 REMARK 3 T33: 0.1834 T12: -0.0134 REMARK 3 T13: 0.0176 T23: -0.0292 REMARK 3 L TENSOR REMARK 3 L11: 1.0540 L22: 0.5393 REMARK 3 L33: 1.9045 L12: 0.0022 REMARK 3 L13: 0.6919 L23: -0.4115 REMARK 3 S TENSOR REMARK 3 S11: 0.0460 S12: 0.0331 S13: 0.0159 REMARK 3 S21: -0.0141 S22: 0.0399 S23: -0.1947 REMARK 3 S31: -0.0637 S32: 0.1314 S33: -0.0895 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: (CHAIN D AND RESID 180:274) REMARK 3 ORIGIN FOR THE GROUP (A): 26.4481 7.4426 36.9327 REMARK 3 T TENSOR REMARK 3 T11: 0.1043 T22: 0.1604 REMARK 3 T33: 0.1216 T12: -0.0046 REMARK 3 T13: 0.0128 T23: -0.0119 REMARK 3 L TENSOR REMARK 3 L11: 0.3641 L22: 0.7722 REMARK 3 L33: 1.7265 L12: -0.2041 REMARK 3 L13: -0.4153 L23: 0.6155 REMARK 3 S TENSOR REMARK 3 S11: 0.1089 S12: 0.0298 S13: 0.0387 REMARK 3 S21: 0.0225 S22: -0.0508 S23: 0.0193 REMARK 3 S31: -0.0459 S32: -0.2921 S33: -0.0412 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: CHAIN E REMARK 3 ORIGIN FOR THE GROUP (A): 36.5520 -10.6009 28.6928 REMARK 3 T TENSOR REMARK 3 T11: 0.1079 T22: 0.1175 REMARK 3 T33: 0.1402 T12: -0.0082 REMARK 3 T13: -0.0288 T23: 0.0193 REMARK 3 L TENSOR REMARK 3 L11: 0.5942 L22: 1.1090 REMARK 3 L33: 0.8925 L12: 0.1723 REMARK 3 L13: 0.1031 L23: -0.2021 REMARK 3 S TENSOR REMARK 3 S11: 0.0991 S12: -0.1447 S13: -0.1098 REMARK 3 S21: 0.0045 S22: 0.0008 S23: -0.0078 REMARK 3 S31: 0.0430 S32: -0.0208 S33: -0.1017 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2X70 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-FEB-10. REMARK 100 THE DEPOSITION ID IS D_1290042985. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-SEP-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0723 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53033 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 81.920 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.22000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1EEY REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOUR DIFFUSION HANGING DROP AT 293K: REMARK 280 2 MICROLITER OF 5 MG/ML PROTEIN IN 0.1 M MES PH 6.0 WAS MIXED REMARK 280 WITH 2 MICROLITER OF 0.1 M MES PH 6.5, 20-22% PEG 1500. SEEDING REMARK 280 WAS USED TO GET BIGGER CRYSTALS, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 40.90050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG D 96 CE1 PHE F 7 2.10 REMARK 500 O PRV F 5 O HOH F 2009 2.17 REMARK 500 CE1 HIS D 191 OD1 ASP E 98 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRQ C 8 CA - C - N ANGL. DEV. = 29.1 DEGREES REMARK 500 GLY F 4 CA - C - N ANGL. DEV. = 17.0 DEGREES REMARK 500 GLY F 4 O - C - N ANGL. DEV. = -21.9 DEGREES REMARK 500 PRV F 5 CA - C - N ANGL. DEV. = -14.5 DEGREES REMARK 500 PRQ F 8 CA - C - N ANGL. DEV. = 27.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 17 43.40 -98.46 REMARK 500 ASP A 29 -123.09 58.05 REMARK 500 ARG A 35 138.51 179.17 REMARK 500 GLN A 180 40.75 -97.46 REMARK 500 SER A 195 -150.87 -130.56 REMARK 500 TRP A 274 98.05 -65.86 REMARK 500 SER B 20 150.29 -49.10 REMARK 500 ASN B 21 -175.54 -171.12 REMARK 500 HIS B 31 135.56 -170.74 REMARK 500 PRO B 32 -175.32 -68.58 REMARK 500 TRP B 60 -7.26 76.55 REMARK 500 PRV C 5 -137.85 -93.08 REMARK 500 VAL C 6 -96.73 -112.88 REMARK 500 PHE C 7 -144.56 89.41 REMARK 500 PRQ C 8 76.32 127.88 REMARK 500 ASP D 28 -121.40 51.63 REMARK 500 PHE D 108 128.34 -24.42 REMARK 500 ARG D 110 146.94 176.23 REMARK 500 HIS D 113 84.34 -152.29 REMARK 500 SER D 194 -167.54 -168.34 REMARK 500 PRO D 209 -178.80 -69.27 REMARK 500 TRP E 60 -7.76 78.66 REMARK 500 ARG E 97 -87.36 -67.16 REMARK 500 ASP E 98 79.68 -46.56 REMARK 500 VAL F 6 -105.59 -109.76 REMARK 500 PHE F 7 -123.13 116.05 REMARK 500 PRQ F 8 104.49 121.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRV C 5 VAL C 6 -131.88 REMARK 500 PRQ C 8 VAL C 9 142.33 REMARK 500 GLY F 4 PRV F 5 -116.46 REMARK 500 PRV F 5 VAL F 6 -133.39 REMARK 500 PRQ F 8 VAL F 9 142.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 PRV C 5 -12.44 REMARK 500 PHE C 7 -14.84 REMARK 500 PRQ C 8 16.70 REMARK 500 GLY F 4 -16.85 REMARK 500 PRV F 5 -19.17 REMARK 500 PHE F 7 18.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH E2015 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH E2019 DISTANCE = 6.69 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1277 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B 1100 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES D 1275 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES D 1277 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 1278 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D 1279 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES E 1100 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A BOUND BACTERIAL REMARK 900 GLYCOLIPID REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, VIRAL PEPTIDE (TAX) AND REMARK 900 MHC CLASS I MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 2ESV RELATED DB: PDB REMARK 900 STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 TCR COMPLEX REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508-13MER REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS PROTEIN US2BOUND TO REMARK 900 THE MHC CLASS I MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2) OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- B(ASTERISK)2705 REMARK 900 RELATED ID: 2AXF RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 2JCC RELATED DB: PDB REMARK 900 AH3 RECOGNITION OF MUTANT HLA-A2 W167A REMARK 900 RELATED ID: 2BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A TELOMERASEPEPTIDE REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 2VLK RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED FC RECEPTOR REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO REMARK 900 ALTERED HTLV-1 TAX PEPTIDE P6A REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW 68.1 (HLA-AW 68.1, REMARK 900 HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEX MOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL KILLER CELLINHIBITORY REMARK 900 RECEPTOR KIR2DL1 BOUND TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 COMPLEXED TOGP2 PEPTIDE REMARK 900 VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ANONAMERIC ALTERED REMARK 900 PEPTIDE LIGAND (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR THE KIR2D NATURAL KILLER REMARK 900 CELL INHIBITORY RECEPTOR REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2 ) TO HLA-A2.1 IS DUE TO A REMARK 900 LACK OF INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS IB MOLECULE M10.5 REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( HLA-A2, HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1JGD RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR HISTOCOMPATIBILITYCOMPLEX, H- REMARK 900 2KD AT 2.0 A RESOLUTION REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING LIGHT CHAIN SHUFFLING: A REMARK 900 STRUCTURAL MODEL FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQA, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) INCOMPLEX REMARK 900 WITH A NONAMERIC PEPTIDE FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 2X4U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO HIV-1 PEPTIDE REMARK 900 RT468-476 REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEXED REMARK 900 WITH A DECAMERIC PEPTIDE FROM CALRETICULIN REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. 1 (HLA-A2.1 HUMAN REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR VIRUS DETERMINANT REMARK 900 RELATED ID: 2X4O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO HIV-1 ENVELOPE REMARK 900 PEPTIDE ENV120-128 REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( 209-217) BOUNDTO HUMAN REMARK 900 CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 2V2W RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SULFATIDE REMARK 900 RELATED ID: 2VLR RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2X4P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A REMARK 900 PHOTOCLEAVABLE PEPTIDE REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH PEPTIDE VPLRPMTYFROM THE REMARK 900 NEF PROTEIN (75- 82) OF HIV1 REMARK 900 RELATED ID: 2BVO RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING AN 11-MER EBVANTIGEN REMARK 900 EPLPQGQLTAY REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH AND WITHOUT ALPHA- REMARK 900 GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF LIGAND EEFGRAYGF REMARK 900 RELATED ID: 2J8U RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION. REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 2X4T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PEIODATE- REMARK 900 CLEAVABLE PEPTIDE REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- DETERMINANT ONHLA-B AND- REMARK 900 C MOLECULES BY THE MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- 1, A HOST ANDVIRAL MHC REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- MICROGLOBULIN REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G DIMER REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITYPROTEIN REMARK 900 (EXTRACELLULAR DOMAIN) COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH A SYNTHETICMYCOBACTIN REMARK 900 LIPOPEPTIDE REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 -MICROGLOBULIN REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN GP100(209-T2M) BOUND REMARK 900 TO HUMAN CLASS I MHC HLA-A2 REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH PEPTIDETYPDINQML FROM REMARK 900 GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM2 (TAFTIPSI) REMARK 900 RELATED ID: 2BVP RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 2V2X RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL CHANGES DURING TCR REMARK 900 ENGAGEMENT. REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN COMPLEX WITH PEPTIDESFROM HUMAN REMARK 900 UBCH6 AND EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2WITH THE REMARK 900 MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 2X4R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO CYTOMEGALOVIRUS REMARK 900 (CMV) PP65 EPITOPE REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN NATURAL KILLER CELL REMARK 900 RECEPTOR KIR2DL2 AND A CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA-AW68 REMARK 900 COMPLEXED WITH A DECAMERIC PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE E63Q AND K66A MUTATIONS IN THEHEAVY CHAIN. REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 REMARK 900 TAX PEPTIDE Y8A REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX PEPTIDE COMPLEX REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 2HJL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201)COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES 271- REMARK 900 279) REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL PEPTIDE (TAX), AND HLA- REMARK 900 A 0201 REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED IMMUNOGENICITY OF T CELL REMARK 900 VACCINES REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF 14-MERICPEPTIDES IN REMARK 900 COMPLEX WITH HLA-B* 3501 REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN COMPLEX WITH HLAB8-EBVPEPTIDE REMARK 900 COMPLEX REMARK 900 RELATED ID: 2H26 RELATED DB: PDB REMARK 900 HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINEAND SPACER REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE ANALOGUE,SLLMWITQS, REMARK 900 IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH PEPTIDE LS6 (KPIVQYDNF) REMARK 900 FROM THE MALARIA PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 2A83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE GLUCAGONRECEPTOR REMARK 900 (GR) PEPTIDE ( RESIDUES 412-420) REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR REMARK 900 RECOGNITION. REMARK 900 RELATED ID: 2F8O RELATED DB: PDB REMARK 900 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED BY ABACKBONE TRIGGER REMARK 900 RELATED ID: 2CII RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED WITH A PARTIAL PEPTIDE REMARK 900 EPITOPE SUGGESTS AN MHC CLASS I ASSEMBLY-INTERMEDIATE REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN COMPLEX WITH ADECAMERIC ALTERED REMARK 900 PEPTIDE LIGAND FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 2C7U RELATED DB: PDB REMARK 900 CONFLICTING SELECTIVE FORCES AFFECT CD8 T- CELL RECEPTOR CONTACT REMARK 900 SITES IN AN HLA-A2 IMMUNODOMINANT HIV EPITOPE. REMARK 900 RELATED ID: 2F74 RELATED DB: PDB REMARK 900 MURINE MHC CLASS I H-2DB IN COMPLEX WITH HUMAN B2-MICROGLOBULIN AND REMARK 900 LCMV-DERIVED IMMUNODMINANT PEPTIDE GP33 REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 COMPLEXED WITH HIV REMARK 900 IMMUNODOMINANT EPITOPE KM1 (LPPVVAKEI) REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE SELF-PEPTIDE TIS REMARK 900 FROM EGF- RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH THE LATENT MEMBRANE REMARK 900 PROTEIN 2 PEPTIDE (LMP2)OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I GLYCOPROTEIN HLA-A2 ANDTHE T CELL REMARK 900 CORECEPTOR CD8 REMARK 900 RELATED ID: 2HJK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 PEPTIDE REMARK 900 RELATED ID: 2VB5 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN BETA2-MICROGLOBULIN REMARK 900 RELATED ID: 2X4N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO RESIDUAL REMARK 900 FRAGMENTS OF A PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON UV-LIGHT REMARK 900 TREATMENT REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 COMPLEXED TOPEPTIDE GP2 REMARK 900 WITH THE SUBSTITUTION (I2L/V5L/L9V) REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- PEPTIDE COMPLEX REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 2VLL RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF THREE IMMUNODOMINANT REMARK 900 VIRAL PEPTIDES COMPLEXED TO HLA-B2705 REMARK 900 RELATED ID: 2VLJ RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL REMARK 900 RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2X4S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. 1 BOUND TO A PEPTIDE REMARK 900 REPRESENTING THE EPITOPE OF THE H5N1 (AVIAN FLU) NUCLEOPROTEIN REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED WITH A PEPTIDE WITH THE REMARK 900 CARBOXYL-TERMINAL GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED WITH THE VASOACTIVE REMARK 900 INTESTINAL PEPTIDE TYPE 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400- REMARK 900 408) REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- A2 COMPLEXED WITH ALTERED REMARK 900 HTLV-1 TAX PEPTIDE V7R REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE BOUND TO HLA-B 3501 DUE REMARK 900 TO NONSTANDARD POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 2AXG RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T CELL EPITOPE ISCONTROLLED REMARK 900 BY ITS MHC-BOUND CONFORMATION REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- PEPTIDE COMPLEXES AND REMARK 900 IDENTIFICATION OF RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG - REMARK 900 TERM NON-PROGRESSION REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE STRUCTURAL CHANGES IN HLA B8 - REMARK 900 HIV-1 GAG PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH IMMUNODOMINANTNONAMER AND REMARK 900 DECAMER HIV-1 EPITOPES CLEARLY REVEAL THEPRESENCE OF A MIDDLE REMARK 900 ANCHOR RESIDUE REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA -A 0201) COMPLEX WITH REMARK 900 A NONAMERIC PEPTIDE FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES 309- REMARK 900 317) REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 EPITOPE, SLLMWITQC,IN REMARK 900 COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR HISTOCOMPATIBILITY COMPLEXMOLECULE REMARK 900 HLA-E REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 2CIK RELATED DB: PDB REMARK 900 INSIGHTS INTO CROSSREACTIVITY IN HUMAN ALLORECOGNITION: THE REMARK 900 STRUCTURE OF HLA-B35011 PRESENTING AN EPITOPE DERIVED FROM REMARK 900 CYTOCHROME P450. REMARK 900 RELATED ID: 2UWE RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( HLA-A2.1) COMPLEXED WITH REMARK 900 BETA 2- MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE BOUND TO HUMANCLASS I MHC REMARK 900 HLA-A2 WITH THE K66A MUTATION IN THE HEAVYCHAIN. REMARK 999 REMARK 999 SEQUENCE REMARK 999 INITIALIZING METHIONINE (B0 AND D0) ADDED TO SEQUENCE REMARK 999 ORIGINAL SEQUENCE IS GILGFVFTL. G AT P1 IS REPLACED BY K DBREF 2X70 A 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 2X70 B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2X70 C 1 9 PDB 2X70 2X70 1 9 DBREF 2X70 D 0 274 UNP P01892 1A02_HUMAN 25 299 DBREF 2X70 E 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2X70 F 1 9 PDB 2X70 2X70 1 9 SEQADV 2X70 MET B 0 UNP P61769 EXPRESSION TAG SEQADV 2X70 MET E 0 UNP P61769 EXPRESSION TAG SEQRES 1 A 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 275 TRP GLU SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 9 LYS ILE LEU GLY PRV VAL PHE PRQ VAL SEQRES 1 D 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 D 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 D 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 D 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 D 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 D 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 D 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 D 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 D 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 D 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 D 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 D 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 D 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 D 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 D 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 D 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 D 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 D 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 D 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 D 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 D 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 D 275 TRP GLU SEQRES 1 E 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 E 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 E 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 E 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 E 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 E 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 E 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 E 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 F 9 LYS ILE LEU GLY PRV VAL PHE PRQ VAL MODRES 2X70 PRV C 5 GLY (2R)-AMINO(2-NITROPHENYL)ETHANOIC ACID MODRES 2X70 PRV F 5 GLY (2R)-AMINO(2-NITROPHENYL)ETHANOIC ACID HET PRV C 5 13 HET PRQ C 8 14 HET PRV F 5 13 HET PRQ F 8 14 HET GOL A1276 6 HET GOL A1277 12 HET MES B1100 12 HET MES D1275 12 HET GOL D1276 6 HET MES D1277 12 HET GOL D1278 12 HET GOL D1279 6 HET MES E1100 12 HETNAM PRV (2R)-AMINO(2-NITROPHENYL)ETHANOIC ACID HETNAM PRQ (3S)-3-AMINO-3-(2-NITROPHENYL)PROPANOIC ACID HETNAM GOL GLYCEROL HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN PRV 2-(NITRO)PHENYLGLYCINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 PRV 2(C8 H8 N2 O4) FORMUL 3 PRQ 2(C9 H10 N2 O4) FORMUL 7 GOL 5(C3 H8 O3) FORMUL 9 MES 4(C6 H13 N O4 S) FORMUL 16 HOH *771(H2 O) HELIX 1 1 ALA A 49 GLU A 53 5 5 HELIX 2 2 GLY A 56 ASN A 86 1 31 HELIX 3 3 ASP A 137 ALA A 150 1 14 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 THR A 225 THR A 228 5 4 HELIX 8 8 GLN A 253 GLN A 255 5 3 HELIX 9 9 ALA D 48 GLU D 52 5 5 HELIX 10 10 GLY D 55 TYR D 84 1 30 HELIX 11 11 ASP D 136 ALA D 149 1 14 HELIX 12 12 HIS D 150 GLY D 161 1 12 HELIX 13 13 GLY D 161 GLY D 174 1 14 HELIX 14 14 GLY D 174 GLN D 179 1 6 HELIX 15 15 THR D 224 THR D 227 5 4 SHEET 1 AA 8 GLU A 46 PRO A 47 0 SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 8 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 AA 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AB 4 LYS A 186 ALA A 193 0 SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AB 4 ARG A 234 PRO A 235 1 O ARG A 234 N GLN A 242 SHEET 1 AC 4 LYS A 186 ALA A 193 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 GLU A 229 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AD 2 ARG A 234 PRO A 235 0 SHEET 2 AD 2 PHE A 241 PRO A 250 1 O GLN A 242 N ARG A 234 SHEET 1 AE 4 GLU A 222 ASP A 223 0 SHEET 2 AE 4 THR A 214 ARG A 219 -1 O ARG A 219 N GLU A 222 SHEET 3 AE 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 AE 4 LEU A 270 ARG A 273 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BA 4 SER B 55 PHE B 56 1 O SER B 55 N TYR B 63 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N PHE B 30 SHEET 4 BB 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BC 2 SER B 55 PHE B 56 0 SHEET 2 BC 2 PHE B 62 PHE B 70 1 O TYR B 63 N SER B 55 SHEET 1 BD 4 GLU B 44 ARG B 45 0 SHEET 2 BD 4 GLU B 36 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BD 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 BD 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 DA 8 GLU D 45 PRO D 46 0 SHEET 2 DA 8 THR D 30 ASP D 36 -1 O ARG D 34 N GLU D 45 SHEET 3 DA 8 ARG D 20 VAL D 27 -1 O ALA D 23 N PHE D 35 SHEET 4 DA 8 HIS D 2 VAL D 11 -1 O ARG D 5 N TYR D 26 SHEET 5 DA 8 THR D 93 VAL D 102 -1 O VAL D 94 N SER D 10 SHEET 6 DA 8 PHE D 108 TYR D 117 -1 N LEU D 109 O ASP D 101 SHEET 7 DA 8 LYS D 120 LEU D 125 -1 O LYS D 120 N TYR D 117 SHEET 8 DA 8 TRP D 132 ALA D 134 -1 O THR D 133 N ALA D 124 SHEET 1 DB 4 LYS D 185 ALA D 192 0 SHEET 2 DB 4 GLU D 197 PHE D 207 -1 O THR D 199 N HIS D 191 SHEET 3 DB 4 PHE D 240 PRO D 249 -1 O PHE D 240 N PHE D 207 SHEET 4 DB 4 ARG D 233 PRO D 234 1 O ARG D 233 N GLN D 241 SHEET 1 DC 4 LYS D 185 ALA D 192 0 SHEET 2 DC 4 GLU D 197 PHE D 207 -1 O THR D 199 N HIS D 191 SHEET 3 DC 4 PHE D 240 PRO D 249 -1 O PHE D 240 N PHE D 207 SHEET 4 DC 4 GLU D 228 LEU D 229 -1 O GLU D 228 N ALA D 245 SHEET 1 DD 2 ARG D 233 PRO D 234 0 SHEET 2 DD 2 PHE D 240 PRO D 249 1 O GLN D 241 N ARG D 233 SHEET 1 DE 4 GLU D 221 ASP D 222 0 SHEET 2 DE 4 THR D 213 ARG D 218 -1 O ARG D 218 N GLU D 221 SHEET 3 DE 4 TYR D 256 GLN D 261 -1 O THR D 257 N GLN D 217 SHEET 4 DE 4 LEU D 269 ARG D 272 -1 O LEU D 269 N VAL D 260 SHEET 1 EA 4 LYS E 6 SER E 11 0 SHEET 2 EA 4 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 EA 4 PHE E 62 PHE E 70 -1 O PHE E 62 N PHE E 30 SHEET 4 EA 4 SER E 55 PHE E 56 1 O SER E 55 N TYR E 63 SHEET 1 EB 4 LYS E 6 SER E 11 0 SHEET 2 EB 4 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 EB 4 PHE E 62 PHE E 70 -1 O PHE E 62 N PHE E 30 SHEET 4 EB 4 GLU E 50 HIS E 51 -1 O GLU E 50 N TYR E 67 SHEET 1 EC 2 SER E 55 PHE E 56 0 SHEET 2 EC 2 PHE E 62 PHE E 70 1 O TYR E 63 N SER E 55 SHEET 1 ED 4 GLU E 44 ARG E 45 0 SHEET 2 ED 4 GLU E 36 LYS E 41 -1 O LYS E 41 N GLU E 44 SHEET 3 ED 4 TYR E 78 ASN E 83 -1 O ALA E 79 N LEU E 40 SHEET 4 ED 4 LYS E 91 LYS E 94 -1 O LYS E 91 N VAL E 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.04 SSBOND 4 CYS D 100 CYS D 163 1555 1555 2.03 SSBOND 5 CYS D 202 CYS D 258 1555 1555 2.04 SSBOND 6 CYS E 25 CYS E 80 1555 1555 2.03 LINK C GLY C 4 N PRV C 5 1555 1555 1.34 LINK C PRV C 5 N VAL C 6 1555 1555 1.33 LINK C PHE C 7 N PRQ C 8 1555 1555 1.33 LINK C PRQ C 8 N VAL C 9 1555 1555 1.33 LINK C GLY F 4 N PRV F 5 1555 1555 1.27 LINK C PRV F 5 N VAL F 6 1555 1555 1.34 LINK C PHE F 7 N PRQ F 8 1555 1555 1.34 LINK C PRQ F 8 N VAL F 9 1555 1555 1.34 CISPEP 1 TYR A 209 PRO A 210 0 3.20 CISPEP 2 HIS B 31 PRO B 32 0 -2.17 CISPEP 3 ASP B 98 MET B 99 0 -8.44 CISPEP 4 TYR D 208 PRO D 209 0 1.45 CISPEP 5 HIS E 31 PRO E 32 0 2.34 SITE 1 AC1 7 ARG A 6 PHE A 8 ASP A 29 ASP A 30 SITE 2 AC1 7 HOH A2029 TYR B 63 MES B1100 SITE 1 AC2 10 ARG A 6 PHE A 8 MET A 98 GLN A 115 SITE 2 AC2 10 HOH A2230 PHE B 56 SER B 57 LYS B 58 SITE 3 AC2 10 TRP B 60 MES B1100 SITE 1 AC3 7 GOL A1276 GOL A1277 SER B 57 LYS B 58 SITE 2 AC3 7 HOH B2072 HOH B2097 HOH B2098 SITE 1 AC4 5 HIS D 191 THR D 199 ARG D 201 ASP E 96 SITE 2 AC4 5 ASP E 98 SITE 1 AC5 5 GLN D 114 ASP D 121 GOL D1278 HOH D2301 SITE 2 AC5 5 LYS E 58 SITE 1 AC6 7 GLU D 231 THR D 232 LYS D 242 HOH D2268 SITE 2 AC6 7 HOH D2302 ASP E 59 MES E1100 SITE 1 AC7 8 ARG D 5 PHE D 7 GLN D 114 GOL D1276 SITE 2 AC7 8 HOH D2149 PHE E 56 SER E 57 LYS E 58 SITE 1 AC8 8 ARG D 5 PHE D 7 TYR D 26 ASP D 28 SITE 2 AC8 8 ASP D 29 HOH D2034 TYR E 63 MES E1100 SITE 1 AC9 7 PHE D 240 MES D1277 GOL D1279 TYR E 26 SITE 2 AC9 7 SER E 57 LYS E 58 TYR E 63 CRYST1 61.979 81.801 79.706 90.00 90.77 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016134 0.000000 0.000217 0.00000 SCALE2 0.000000 0.012225 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012547 0.00000